Press Releases
Please click here if you wish to receive an e-mail notification regarding Alector press releases.
Sep 09, 2019
Alector Initiates Phase 2 Trial of AL001 in Patients with Frontotemporal Dementia
Sep 03, 2019
Alector to Present at 17th Annual Morgan Stanley Global Healthcare Conference
Aug 12, 2019
Alector Reports Recent Business Highlights and Second Quarter 2019 Financial Results
Aug 12, 2019
Alector Announces the Addition of Kristine Yaffe, M.D., to the Board of Directors
Jul 17, 2019
Alector Announces Data from On-going Phase 1b Trial Demonstrating that AL001 Reverses Progranulin Deficiency in Frontotemporal Dementia Patients
Jul 11, 2019
Alector Announces Upcoming Presentations at 2019 Alzheimer's Association International Conference
May 13, 2019
Alector Reports Recent Business Highlights and First Quarter 2019 Financial Results
May 08, 2019
Alector to Present at the Bank of America Merrill Lynch Healthcare Conference on May 15, 2019
May 06, 2019
Alector Announces First Alzheimer’s Disease Patient Dosed in Phase 1b Study of AL002
Apr 17, 2019
Alector Announces First Frontotemporal Dementia Patient Dosed in Phase 1b Study of AL001
Displaying 1 - 10 of 14